Publications & Abstracts

The duodenal-jejunal bypass liner (DJBL) is a promising technique for treating obesity and type 2 diabetes mellitus (T2DM). However, despite...

The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this...

The duodenal-jejunal bypass liner (DJBL) is a new, device-based endoscopic treatment for type 2 diabetes mellitus (T2DM) and obesity.

On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with...

Investigate the safety and efficacy of 6 months’ duodenal-jejunal bypass liner (DJBL) treatment in comparison with dietary intervention for...

The Endobarrier gastrointestinal liner system (by GI Dynamics®) is an endoscopically-delivered device that offers an alternative to gastric bypass...

The endoscopically delivered duodenal-jejunal bypass liner (DJBL) exhibits robust metabolic effects in obese subjects with type 2 diabetes...

Endoscopic implantation of a duodenal-jejunal bypass liner (DJBL) is a novel bariatric technique to induce weight loss and remission of type 2...

This study was performed to determine the safety, efficacy, and feasibility of delivering the DJBL with the patient under conscious sedation...

We recommend consideration of the DJBS as a therapy alternative for the treatment of adult patients (minimum age: 18 years) with type 2 diabetes...